Analysis of pancreatic peptide hormones by reversed-phase high-performance liquid chromatography.
Reversed-phase high-performance liquid chromatography (HPLC) is examined as a method for separating pancreatic peptides. The method was based on gradient elution with acetonitrile in an acid phosphate buffer (pH 3.10). Apart from human and porcine insulin all the other peptide standards tested (thyrotropin-releasing factor, vaso-active intestinal polypeptide, human C-peptide, porcine C-peptide, somatostatin, porcine glucagon, porcine proinsulin and porcine pancreatic polypeptide) could be separated simultaneously in 40 minutes with a binary gradient composed of five linear segments and increasing from 0 to 60% acetonitrile. Human and porcine insulin could be almost completely resolved by a minimal reduction in the steepness of the acetonitrile gradient. Repeated injections of human C-peptide and porcine insulin resulted in a coefficient of variation of less than 1.5% in the retention times. The use of 125I-labelled peptides gave recoveries exceeding 90%. HPLC of acid ethanol extracts of autopsy pancreases from three infants showed that the immunoreactivity of the peptides measured remained unaffected by the chromatography. Both immunoreactive C-peptide and immunoreactive insulin (IRI) were recovered in two peaks, the second common peak representing proinsulin and amounting to 6.5 to 8.4% of total IRI. Immunoreactive glucagon was eluted in a single peak. Chromatography of plasma extracts from two infants of diabetic mothers demonstrated that proinsulin accounted for 59-63% of total IRI, while insulin was separated into two peaks corresponding to the standards of human insulin and porcine insulin. These results indicate that reversed -phase HPLC is a method with a good reproducibility and a high recovery applicable to the rapid and effective separation of pancreatic peptides from biological extracts.
D000818:Animals; D002096:C-Peptide / Q000302:isolation & purification; D002851:Chromatography, High Pressure Liquid; D005934:Glucagon / Q000302:isolation & purification; D006728:Hormones / Q000097:blood / Q000302:isolation & purification*; D006801:Humans; D007223:Infant; D007328:Insulin / Q000302:isolation & purification; D010179:Pancreas / Q000032:analysis*; D010191:Pancreatic Polypeptide / Q000302:isolation & purification; D010455:Peptides / Q000302:isolation & purification*; D011384:Proinsulin / Q000302:isolation & purification; D011863:Radioimmunoassay; D013004:Somatostatin / Q000302:isolation & purification; D013552:Swine; D013973:Thyrotropin-Releasing Hormone / Q000302:isolation & purification; D014660:Vasoactive Intestinal Peptide / Q000302:isolation & purification
D002096:C-Peptide; D006728:Hormones; D007328:Insulin; D010455:Peptides; D014660:Vasoactive Intestinal Peptide; D013004:Somatostatin; D010191:Pancreatic Polypeptide; D013973:Thyrotropin-Releasing Hormone; D005934:Glucagon; D011384:Proinsulin